Sectors

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Daily leader from editor-in-chief James Mawson.

There are occasional silver linings even for the blackest clouds. One was as the Covid-19 disease broke out this year competition for deals became a little lighter.

Omega Therapeutics is firing up preclinical development of an epigenomic drug platform invented at Whitehead Institute and incubated by Flagship Pioneering.

Nura Bio is working on neuroprotective treatments that exploit discoveries made at OHSU and UT Southwestern.

Tech Launch Arizona has crossed the milestone of 100 spinouts in its portfolio after achieving a new annual record in the 2019-2020 fiscal year.

Meituan Dianping and Bytedance were among the shareholders that committed to investing $380m in a concurrent private placement.

Cerevel Therapeutics, co-founded by Pfizer, is set to undertake a reverse merger with Nasdaq-listed Arya II in a deal that will give Cerevel a market cap of $1.3bn.

The fund will invest in companies developing products and services within the cryptocurrency exchange’s ecosystem.

The creative digital studio has floated on TSE’s Mothers Market, enabling Kaga Electronics, Sony and Norinchukin Bank to exit.

Backed by Cambria Health Solutions and Link-Age, True Link has now raised $50m in all to provide financial services geared toward vulnerable groups.